Total Payments
$59,913
2024 Payments
$5,951
Companies
86
Transactions
1,233
Medicare Patients
4,985
Medicare Billing
$718,407
Payment Breakdown by Category
Food & Beverage$26,705 (44.6%)
Education$11,850 (19.8%)
Consulting$11,200 (18.7%)
Travel$9,159 (15.3%)
Other$1,000 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,705 | 1,171 | 44.6% |
| Education | $11,850 | 24 | 19.8% |
| Consulting Fee | $11,200 | 5 | 18.7% |
| Travel and Lodging | $9,159 | 32 | 15.3% |
| Honoraria | $1,000 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Interventional Pain Technologies Inc. | $14,500 | 10 | $0 (2022) |
| Nevro Corp. | $7,414 | 180 | $0 (2024) |
| Boston Scientific Corporation | $5,803 | 39 | $0 (2024) |
| Abbott Laboratories | $3,339 | 125 | $0 (2024) |
| SurGenTec | $3,229 | 3 | $0 (2024) |
| Camber Spine Technologies LLC | $3,000 | 2 | $0 (2022) |
| Saluda Medical Americas, Inc. | $1,922 | 22 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,790 | 123 | $0 (2024) |
| Vertiflex, Inc. | $1,500 | 23 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $1,334 | 28 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,951 | 124 | SurGenTec ($3,075) |
| 2023 | $5,469 | 124 | Saluda Medical Americas, Inc. ($1,679) |
| 2022 | $20,520 | 131 | Interventional Pain Technologies Inc. ($14,500) |
| 2021 | $2,928 | 123 | Nalu Medical, Inc. ($439.11) |
| 2020 | $4,033 | 134 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($1,086) |
| 2019 | $10,296 | 178 | Boston Scientific Corporation ($4,763) |
| 2018 | $4,478 | 199 | Vertos Medical, Inc. ($875.82) |
| 2017 | $6,239 | 220 | Nevro Corp. ($1,619) |
All Payment Transactions
1,233 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 12/23/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 12/17/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/09/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $82.46 | General |
| Category: Pain Management | ||||||
| 12/04/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: Opioid Analgesic | ||||||
| 11/27/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 11/27/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 11/25/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/20/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 11/20/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 11/13/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/07/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: Opioid Analgesic | ||||||
| 10/31/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Neuromodulation | ||||||
| 10/24/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 10/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $9.66 | General |
| Category: Opioid Analgesic | ||||||
| 10/22/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 10/22/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 10/18/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/08/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/01/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Opioid Analgesic | ||||||
| 09/30/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/24/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/21/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $133.50 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 899 | 1,710 | $1.1M | $126,356 |
| 2022 | 24 | 1,124 | 8,950 | $1.6M | $194,890 |
| 2021 | 25 | 1,319 | 2,526 | $1.9M | $190,067 |
| 2020 | 31 | 1,643 | 3,762 | $2.3M | $207,095 |
Total Patients
4,985
Total Services
16,948
Medicare Billing
$718,407
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 524 | $209,600 | $45,218 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 214 | 558 | $273,420 | $33,101 | 12.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 194 | 293 | $131,850 | $17,598 | 13.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $129,340 | $13,225 | 10.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 19 | 21 | $56,700 | $3,879 | 6.8% |
| 62369 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump | Office | 2023 | 19 | 42 | $32,550 | $2,322 | 7.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 11 | 12 | $24,000 | $2,254 | 9.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 23 | 29 | $78,300 | $2,042 | 2.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 14 | 22 | $4,400 | $1,899 | 43.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 11 | 15 | $21,000 | $1,436 | 6.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 24 | $21,600 | $1,182 | 5.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 11 | 15 | $21,000 | $822.48 | 3.9% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 11 | 12 | $24,000 | $741.29 | 3.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 11 | 12 | $48,000 | $549.48 | 1.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 15 | $2,025 | $85.10 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 708 | $283,200 | $62,603 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 227 | 587 | $287,630 | $35,029 | 12.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 16 | 6,800 | $122,400 | $33,328 | 27.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 181 | 290 | $130,500 | $17,269 | 13.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $80,280 | $8,847 | 11.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 44 | 56 | $151,200 | $4,291 | 2.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 16 | 35 | $18,025 | $4,190 | 23.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 15 | 17 | $34,000 | $3,538 | 10.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 16 | 21 | $56,700 | $3,518 | 6.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 28 | 46 | $6,900 | $2,889 | 41.9% |
About Dr. Steve Lee, MD
Dr. Steve Lee, MD is a Interventional Pain Medicine healthcare provider based in Slidell, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699971465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steve Lee, MD has received a total of $59,913 in payments from pharmaceutical and medical device companies, with $5,951 received in 2024. These payments were reported across 1,233 transactions from 86 companies. The most common payment nature is "Food and Beverage" ($26,705).
As a Medicare-enrolled provider, Lee has provided services to 4,985 Medicare beneficiaries, totaling 16,948 services with total Medicare billing of $718,407. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Anesthesiology
- Location Slidell, LA
- Active Since 06/26/2007
- Last Updated 08/26/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699971465
Products in Payments
- SPECTRA WAVEWRITER (Device) $4,952
- Senza Spinal Cord Stimulation System (Device) $4,949
- ION (Device) $3,075
- Evoke SCS (Device) $1,679
- Superion ISS (Device) $1,500
- Omnia (Device) $1,297
- Intracept (Device) $1,173
- Senza (Device) $1,167
- SACROILIAC JOINT FUSION SYSTEM (Device) $1,134
- Proclaim Family of SCS IPGs (Device) $920.70
- mild Device Kit (Device) $911.14
- XTAMPZA (Drug) $905.64
- Probuphine (Drug) $779.71
- PROCLAIM (Device) $647.45
- Nalu Neurostimulation System (Device) $629.19
- Belbuca (Drug) $534.28
- LYRICA (Drug) $502.86
- Horizant (Drug) $492.65
- HA MINUTEMAN G3-R (Device) $468.24
- ETERNA (Device) $457.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.